{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:47:58Z","timestamp":1760986078937,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002553"],"award-info":[{"award-number":["UL1TR002553"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajem.2021.11.037","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T12:52:03Z","timestamp":1638190323000},"page":"220-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of intermittent versus continuous infusion antihypertensives in acute ischemic stroke"],"prefix":"10.1016","volume":"52","author":[{"given":"Ashley","family":"Kamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wennie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Lassiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyansh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridgette","family":"Kram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajem.2021.11.037_bb0005","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association\/American Stroke A","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ajem.2021.11.037_bb0010","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/STROKEAHA.109.548602","article-title":"Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (SITS-ISTR)","volume":"40","author":"Ahmed","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ajem.2021.11.037_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/STROKEAHA.109.563767","article-title":"Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation","volume":"41","author":"Butcher","year":"2010","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ajem.2021.11.037_bb0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12975-016-0458-6","article-title":"Systolic blood pressure variability is associated with severe hemorrhagic transformation in the early stage after thrombolysis","volume":"7","author":"Liu","year":"2016","journal-title":"Transl Stroke Res"},{"issue":"24","key":"10.1016\/j.ajem.2021.11.037_bb0025","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ajem.2021.11.037_bb0030","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajem.2021.11.037_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JNN.0000000000000170","article-title":"Time to blood pressure control before thrombolytic therapy in patients with acute ischemic stroke: comparison of labetalol, nicardipine, and hydralazine","volume":"47","author":"McKay","year":"2015","journal-title":"J Neurosci Nurs"},{"issue":"2","key":"10.1016\/j.ajem.2021.11.037_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12028-016-0349-4","article-title":"Clevidipine versus nicardipine for acute blood pressure reduction in a neuroscience intensive care population","volume":"26","author":"Finger","year":"2017","journal-title":"Neurocrit Care"},{"issue":"8","key":"10.1016\/j.ajem.2021.11.037_bb0045","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.03.001","article-title":"Comparison of nicardipine with clevidipine in the management of hypertension in acute cerebrovascular diseases","volume":"27","author":"Rosenfeldt","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.ajem.2021.11.037_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12028-013-9863-9","article-title":"A prospective evaluation of labetalol versus nicardipine for blood pressure management in patients with acute stroke","volume":"19","author":"Liu-Deryke","year":"2013","journal-title":"Neurocrit Care"},{"issue":"2","key":"10.1016\/j.ajem.2021.11.037_bb0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ajem.2021.11.037_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"8","key":"10.1016\/j.ajem.2021.11.037_bb0065","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.1993.00540080060015","article-title":"Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography","volume":"50","author":"Lisk","year":"1993","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.ajem.2021.11.037_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/cc10289","article-title":"CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department","volume":"15","author":"Peacock","year":"2011","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.ajem.2021.11.037_bb0075","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.110.974675","article-title":"Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes","volume":"123","author":"Fonarow","year":"2011","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ajem.2021.11.037_bb0080","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage","volume":"368","author":"Anderson","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajem.2021.11.037_bb0085","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral hemorrhage","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721009438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721009438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:58:01Z","timestamp":1760025481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721009438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":17,"alternative-id":["S0735675721009438"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.11.037","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of intermittent versus continuous infusion antihypertensives in acute ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}